Failure of immunotherapy in high-grade serous ovarian cancer (HGSC) may be due to high levels of transforming growth factor-β (TGF-β) in ascites or tumour immune microenvironment (TIME). Here, we test ...

The primary endpoints were safety and tolerability including drug-related grade ≥3 AEs, study drug-related AEs, IRAEs and AEs corresponding to retroviral rebound syndrome and the pharmacokinetics of ...